200
Participants
Start Date
June 30, 2016
Primary Completion Date
December 31, 2019
Study Completion Date
December 31, 2019
Anti-TNF
NOT_YET_RECRUITING
Hospital San Cecilio, Granada
NOT_YET_RECRUITING
Hospital Carlos Haya, Málaga
NOT_YET_RECRUITING
Hospital Virgen del Rocio, Seville
NOT_YET_RECRUITING
Hospital Son LLatzer, Palma de Mallorca
NOT_YET_RECRUITING
Hospital de Basurto, Bilbao
NOT_YET_RECRUITING
Hospital Universitario de Canarias, San Cristóbal de La Laguna
NOT_YET_RECRUITING
Hospital Marques de Valdecilla, Santander
NOT_YET_RECRUITING
Hospital de Guadalajara, Guadalajara
NOT_YET_RECRUITING
Clínic de Barcelona, Barcelona
NOT_YET_RECRUITING
Hospital de Santa Creu i Sant Pau, Barcelona
NOT_YET_RECRUITING
Hospital de Bellvitge, L'Hospitalet de Llobregat
NOT_YET_RECRUITING
Hospital Moises Broggi, Sant Joan Despí
NOT_YET_RECRUITING
Complexo Hospitalaria A Coruña, A Coruña
NOT_YET_RECRUITING
Hospital Clínico San Carlos, Madrid
NOT_YET_RECRUITING
Hospital Infanta Sofía, Madrid
NOT_YET_RECRUITING
Hospital La Paz, Madrid
NOT_YET_RECRUITING
Hospital Puerta de Hierro, Madrid
NOT_YET_RECRUITING
Hospital Virgen de la Arreixaca, Murcia
RECRUITING
Hospital Vall d'Hebron, Barcelona
Collaborators (1)
UCB Pharma
INDUSTRY
Hospital Universitari Vall d'Hebron Research Institute
OTHER